Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy

Catheterization and Cardiovascular Interventions

Volumn 86, Issue 4, 2015, Pages 644-652

  Kawamoto, Hiroyoshi ^a,b,d   Latib, Azeem ^a,b   Ruparelia, Neil ^a,b,c   Miyazaki, Tadashi ^a,b   Sticchi, Alessandro ^a   Naganuma, Toru ^d   Sato, Katsumasa ^e   Figini, Filippo ^a,b   Chieffo, Alaide ^a   Carlino, Mauro ^a   Montorfano, Matteo ^a   Colombo, Antonio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NEW TOKYO HOSPITAL   (Japan)

^e Fukuyama Cardiovascular Hospital   (Japan)

Author keywords

bioresorbable scaffold; coronary bifurcation; double stenting; provisional stenting

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BIORESORBABLE SCAFFOLD; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY BIFURCATION LESION; CORONARY STENTING; DEVICE SAFETY; DRUG ELUTING STENT; FEMALE; HEART DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TREATMENT OUTCOME; AGED; BIODEGRADABLE IMPLANT; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; ECHOGRAPHY; FOLLOW UP; INTERVENTIONAL ULTRASONOGRAPHY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PROCEDURES; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; STENT; SURVIVAL RATE; TISSUE SCAFFOLD; TRANSLUMINAL CORONARY ANGIOPLASTY;

ABSORBABLE IMPLANTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; STENTS; SURVIVAL RATE; TISSUE SCAFFOLDS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84941959948     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26045     Document Type: Article

References (33)

1. Serruys PW, Ormiston JA, Onuma Y, et al., A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009; 373: 897-910.
2. Onuma Y, Serruys PW,. Bioresorbable scaffold: The advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011; 123: 779-797.
3. Brugaletta S, Gori T, Low AF, et al., Absorb bioresorbable vascular scaffold versus Everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: The BVS-EXAMINATION study (bioresorbable vascular Scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction). JACC Cardiovasc Interv 2015; 8: 189-197.
4. Vaquerizo B, Barros A, Pujadas S, et al., Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study. EuroIntervention 2014.pii: 20140601-04.
5. Ielasi A, Latib A, Naganuma T, et al., Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis. Int J Cardiol 2014; 173: 513-514.
6. Muramatsu T, Onuma Y, Garcia-Garcia HM, et al., Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: An interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv 2013; 6: 247-257.
7. Abizaid A, Costa JR Jr, Bartorelli AL, et al., The ABSORB EXTEND study: Preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. Eurointervention 2015; 10: 1396-1401.
8. Capodanno D, Gori T, Nef H, et al., Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: Early and midterm outcomes from the european multicentre GHOST-EU registry. EuroIntervention 2015; 10: 1144-1153.
9. Colombo A, Moses JW, Morice MC, et al., Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249.
10. Song YB, Hahn JY, Yang JH, et al., Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: Results from the COBIS (coronary bifurcation stenting) registry II. JACC Cardiovasc Interv 2014; 7: 255-263.
11. Lassen JF, Holm NR, Stankovic G, et al., Percutaneous coronary intervention for coronary bifurcation disease: Consensus from the first 10 years of the european bifurcation club meetings. EuroIntervention 2014; 10: 545-560.
12. Laskey WK, Yancy CW, Maisel WH,. Thrombosis in coronary drug-eluting stents: Report from the meeting of the circulatory system medical devices advisory panel of the food and drug administration center for devices and radiologic health, december 7-8, 2006. Circulation 2007; 115: 2352-2357.
13. Colombo A, Bramucci E, Sacca S, et al., Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: The CACTUS (coronary bifurcations: Application of the crushing technique using Sirolimus-eluting stents) study. Circulation 2009; 119: 71-78.
14. Hildick-Smith D, de Belder AJ, Cooter N, et al., Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: The british bifurcation coronary study: Old, new, and evolving strategies. Circulation 2010; 121: 1235-1243.
15. Steigen TK, Maeng M, Wiseth R, et al., Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The nordic bifurcation study. Circulation 2006; 114: 1955-1961.
16. Tamburino C, Latib A, van Geuns RJ, et al., Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: A European perspective. EuroIntervention 2015; 10.
17. Lansky AJ, Yaqub M, Hermiller JB, et al., Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: Three-year results from the SPIRIT III randomised trial. EuroIntervention 2010; 6: J44-J52.
18. Popma JJ, Mauri L, O'Shaughnessy C, et al., Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circ Cardiovasc Interv 2009; 2: 133-139.
19. Sato K, Panoulas VF, Kawamoto H, et al., Side branch occlusion after bioresorbable vascular scaffold implantation: Lessons from optimal coherence tomography. JACC Cardiovasc Interv 2015; 8: 116-118.
20. Ormiston JA, Webber B, Ubod B, et al., An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition). Eurointervention 2015; 11: 60-67.
21. Ormiston JA, Webber B, Ubod B, et al., Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: A bench study of deployment, side branch dilatation and post-dilatation strategies. EuroIntervention 2015; 10: 1169-1177.
22. Lansky AJ, Stone GW,. Periprocedural myocardial infarction: Prevalence, prognosis, and prevention. Circ Cardiovasc Interv 2010; 3: 602-610.
23. Prasad A, Herrmann J,. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 2011; 364: 453-464.
24. Thygesen K, Alpert JS, Jaffe AS, et al., The writing group on behalf of the joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-1598.
25. Moussa ID, Klein LW, Shah B, et al., Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document from the society for cardiovascular angiography and interventions (SCAI). Catheter Cardiovasc Interv 2014; 83: 27-36.
26. Serruys PW, Chevalier B, Dudek D, et al., A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet 2015; 385: 43-54.
27. Chen SL, Santoso T, Zhang JJ, et al., A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: Results from the DKCRUSH-II (double kissing crush versus provisional stenting technique for treatment of coronary bifurcation lesions) trial. J Am Coll Cardiol 2011; 57: 914-920.
28. Latib A, Colombo A,. Bifurcation disease: What do we know, what should we do? JACC Cardiovasc Interv 2008; 1: 218-226.
29. Erglis A, Kumsars I, Niemela M, et al., Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: The nordic stent technique study. Circ Cardiovasc Interv 2009; 2: 27-34.
30. Prati F, Regar E, Mintz GS, et al., Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: Physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010; 31: 401-415.
31. Mintz GS, Garcia-Garcia HM, Nicholls SJ, et al., Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. EuroIntervention 2011; 6: 1123-1130, 9.
32. Guagliumi G, Capodanno D, Ikejima H, et al., Impact of different stent alloys on human vascular response to everolimus-eluting stent: An optical coherence tomography study: The OCTEVEREST. Catheter Cardiovasc Interv 2013; 81: 510-518.
33. Parodi G, La Manna A, Di Vito L, et al., Stent-related defects in patients presenting with stent thrombosis: Differences at optical coherence tomography between subacute and late/very late thrombosis in the mechanism of stent thrombosis (MOST) study. EuroIntervention 2013; 9: 936-944.